Aberrant protein expression of transcription factors BACH1 and ERG, both encoded on chromosome 21, in brains of patients with Down syndrome and Alzheimer's disease

Journal of Neural Transmission, Supplement

Volumn , Issue 67, 2003, Pages 39-49

  Shim, K S ^a   Ferrando Miguel, R ^a   Lubec, G ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BACH 1; TRANSCRIPTION FACTOR ERG; TRANSCRIPTION FACTOR RUNX 1; TRANSCRIPTION FACTOR SIM 1; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN; CHROMOSOME 21; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FRONTAL CORTEX; GENE DOSAGE; HUMAN; HUMAN TISSUE; MALE; NEUROPATHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 1542405156     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6721-2_3     Document Type: Article

References (54)

1. Asou N (2003) The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications. Crit Rev Oncol Hematol 45: 129-150
2. Aziz-Aloya RB, Levanon D, Karn H, Kidron D, Goldenberg D, Lotem J, Polak-Chaklon S, Groner Y (1998) Expression of AML1-d, a short human AML1 isoform, in embryonic stem cells suppresses in vivo tumor growth and differentiation. Cell Death Differ 5: 765-773
3. Basuyaux JP, Ferreira E, Stehelin D, Buttice G (1997) The Ets transcription factors interact with each other and with the c-Fos/c-Jun complex via distinct protein domains in a DNA-dependent and -independent manner. J Biol Chem 272: 26188-26195
4. Bernardin F, Friedman AD (2002) AML1 stimulates G1 to S progression via its transactivation domain. Oncogene 21: 3247-3252
5. Blom N, Gammeltoft S, Brunak S (1999) Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 294: 1351-1362
6. Cairns NJ (1999) Neuropathology. J Neural Transm [Suppl] 57: 61-74
7. Cheon MS, Bajo M, Kim SH, Claudio JO, Stewart AK, Patterson D, Kruger WD, Kondoh H, Lubec G (2003) Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis, part II. Amino Acids 24: 119-125
8. Cheon MS, Kim SH, Ovod V, Kopitar Jerala N, Morgan JI, Hatefi Y, Ijuin T, Takenawa T, Lubec G (2003) Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis, part III. Amino Acids 24: 127-134
9. Cheon MS, Kim SH, Yaspo ML, Blasi F, Aoki Y, Melen K, Lubec G (2003) Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis, part I. Amino Acids 24: 111-117
10. Cheon MS, Shim KS, Kim SH, Hara A, Lubec G (2003) Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis, part IV. Amino Acids 25: 41-47
11. Chrast R, Scott HS, Madani R, Huber L, Wolfer DP, Prinz M, Aguzzi A, Lipp HP, Antonarakis SE (2000) Mice trisomic for a bacterial artificial chromosome with the single-minded 2 gene (Sim2) show phenotypes similar to some of those present in the partial trisomy 16 mouse models of Down syndrome. Hum Mol Genet 9: 1853-1864
12. Ema M, Ikegami S, Hosoya T, Mimura J, Ohtani H, Nakao K, Inokuchi K, Katsuki M, Fujii-Kuriyama Y (1999) Mild impairment of learning and memory in mice overexpressing the mSim2 gene located on chromosome 16: an animal model of Down's syndrome. Hum Mol Genet 8: 1409-1415
13. Engidawork E, Lubec G (2003) Molecular changes in fetal Down syndrome brain. J Neurochem 84: 895-904
14. Engidawork E, Balic N, Fountoulakis M, Dierssen M, Greber-Platzer S, Lubec G (2001) Beta-amyloid precursor protein, ETS-2 and collagen alpha 1 (VI) chain precursor, encoded on chromosome 21, are not overexpressed in fetal Down syndrome: further evidence against gene dosage effect. J Neural Transm [Suppl] 61: 335-346
15. th edn, vol I. McGraw Hill, New York, pp 749-794
16. Fan CM, Kuwana E, Bulfone A, Fletcher CF, Copeland NG, Jenkins NA, Crews S, Martinez S, Puelles L, Rubenstein LR, Tessier-Lavigne M (1996) Expression patterns of two murine homologs of Drosophila single-minded suggest possible roles in embryonic patterning and in the pathogenesis of Down syndrome. Mol Cell Neurosci 7: 1-16
17. Fang-Kircher SG, Labudova O, Kitzmueller E, Rink H, Cairns N, Lubec G (1999) Increased steady state mRNA levels of DNA-repair genes XRCC1, ERCC2 and ERCC3 in brain of patients with Down syndrome. Life Sci 64: 1689-1699
18. Ferrando-Miguel R, Lubec G (2003) Overexpression of transciption factor BACH1 in fetal Down syndrome brain. J Neural Transm [Suppl] 67 (this volume)
19. Freidl M, Gulesserian T, Lubec G, Fountoulakis M, Lubec B (2001) Deterioration of the transcriptional, splicing and elongation machinery in brain of fetal Down syndrome. J Neural Transm [Suppl] 61: 47-57
20. Greber-Platzer S, Balcz B, Cairns N, Lubec G (1999) c-fos expression in brains of patients with Down syndrome. J Neural Transm [Suppl] 57: 75-85
21. Guenal I, Risler Y, Mignotte B (1997) Down-regulation of actin genes precedes microfilament network disruption and actin cleavage during p53-mediated apoptosis. J Cell Sci 110: 489-495
22. Gulesserian T, Engidawork E, Fountoulakis M, Lubec G (2001) Antioxidant proteins in fetal brain: superoxide dismutase-1 (SOD-1) protein is not overexpressed in fetal Down syndrome. J Neural Transm [Suppl] 61: 71-84
23. He X, Rosenfeld MG (1991) Mechanisms of complex transcriptional regulation: implications for brain development. Neuron 7: 183-196
24. Hewett PW, Nishi K, Daft EL, Clifford Murray J (2001) Selective expression of erg isoforms in human endothelial cells. Int J Biochem Cell Biol 33: 347-355
25. Katsuoka F, Motohashi H, Tamagawa Y, Kure S, Igarashi K, Engel JD, Yamamoto M (2003) Small Maf compound mutants display central nervous system neuronal degeneration, aberrant transcription, and Bach protein mislocalization coincident with myoclonus and abnormal startle response. Mol Cell Biol 23: 1163-1174
26. Kitamuro T, Takahashi K, Ogawa K, Udono-Fujimori R, Takeda K, Furuyama K, Nakayama M, Sun J, Fujita H, Hida W, Hattori T, Shirato K, Igarashi K, Shibahara S (2003) Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells. J Biol Chem 278: 9125-9133
27. Labudova O, Krapfenbauer K, Moenkemann H, Rink H, Kitzmuller E, Cairns N, Lubec G (1998) Decreased transcription factor junD in brains of patients with Down syndrome. Neurosci Lett 252: 159-162
28. Labudova O, Kitzmueller E, Rink H, Cairns N, Lubec G (1999) Gene expression in fetal Down syndrome brain as revealed by subtractive hybridization. J Neural Transm [Suppl] 57: 125-136
29. LeBlanc A (1998) Detection of actin cleavage in Alzheimer's disease. Am J Pathol 152: 329-332
30. Levanon D, Brenner O, Negreanu V, Bettoun D, Woolf E, Eilam R, Lotem J, Gat U, Otto F, Speck N, Groner Y (2001) Spatial and temporal expression pattern of Runx3 (Aml2) and Runx1 (Aml1) indicates non-redundant functions during mouse embryogenesis. Mech Dev 109: 413-411
31. Lubec G, Engidawork E (2002) The brain in Down syndrome (TRISOMY 21). J Neurol 249: 1347-1356
32. Maroulakou IG, Bowe DB (2000) Expression and function of Ets transcription factors in mammalian development: a regulatory network. Oncogene 19: 6432-6442
33. Mazzola JL, Sirover MA (2002) Alteration of intracellular structure and function of glyceraldehyde-3-phosphate dehydrogenase: a common phenotype of neurodegenerative disorders. Neurotoxicology 23: 603-609
34. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Part 2 Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486
35. Moffett P, Dayo M, Reece M, McCormick MK, Pelletier J (1996) Characterization of msim, a murine homologue of the Drosophila sim transcription factor. Genomics 35: 144-155
36. Muenke M, Bone LJ, Mitchell HF, Hart I, Walton K, Hall-Johnson K, Ippel EF, Dietz-Band J, Kvaloy K, Fan CM (1995) Physical mapping of the holoprosencephaly critical region in 21q22.3, exclusion of SIM2 as a candidate gene for holoprosencephaly, and mapping of SIM2 to a region of chromosome 21 important for Down syndrome. Am J Hum Genet 57: 1074-1079
37. Nicham R, Weitzdörfer R, Hauser E, Freidl M, Schubert M, Wurst E, Lubec G, Seidl R (2003) Spectrum of cognitive, behavioural and emotional problems in children and young adults with Down syndrome. J Neural Transm [Suppl 67] (this volume)
38. Ogawa K, Sun J, Taketani S, Nakajima O, Nishitani C, Sassa S, Hayashi N, Yamamoto M, Shibahara S, Fujita H, Igarashi K (2001) Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1. EMBO J 20: 2835-2843
39. Okuda T, van Deursen J, Hiebert JW, Grosveld G, Downing JR (1996) AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84: 321-330
40. Oyake T, Itoh K, Motohashi H, Hayashi N, Hoshino H, Nishizawa M, Yamamoto M, Igarashi K (1996) Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol Cell Biol 16: 6083-6095
41. Perry C, Eldor A, Soreq H (2002) Runx1/AML1 in leukemia: disrupted association with diverse protein partners. Leuk Res 26: 221-228
42. Perry C, Sklan EH, Birikh K, Shapira M, Trejo L, Eldor A, Soreq H (2002) Complex regulation of acetylcholinesterase gene expression in human brain tumors. Oncogene 21: 8428-8441
43. Sawa A (1999) Neuronal cell death in Down's syndrome. J Neurol Transm [Suppl] 57: 87-97
44. Schipper HM (2000) Heme oxygenase-1: role in brain aging and neurodegeneration. Exp Gerontol 35: 821-830
45. Sun J, Hoshino H, Takaku K, Nakajima O, Muto A, Suzuki H, Tashiro S, Takahashi S, Shibahara S, Alam J, Taketo MM, Yamamoto M, Igarashi K (2002) Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J 21: 5216-5224
46. Tierney MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P (1998) The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 38: 359-364
47. Trojanowska M (2000) Ets factors and regulation of the extracellular matrix. Oncogene 19: 6464-6471
48. Tsuji K, Noda M (2000) Identification and expression of a novel 3′-exon of mouse Runx1/Pebp2 alphaB/Cbfa2/AML1 gene. Biochem Biophys Res Commun 274: 171-176
49. Verger A, Buisine E, Carrere S, Wintjens R, Flourens A, Coll J, Stehelin D, Duterque-Coquillaud M (2000) Identification of amino acid residues in the ETS transcription factor Erg that mediate Erg-Jun/Fos-DNA ternary complex formation. J Biol Chem 276: 17181-17189
50. Vialard F, Toyama K, Vernoux S, Carlson EJ, Epstein CJ, Sinet PM, Rahmani Z (2000) Overexpression of mSim2 gene in the zona limitans of the diencephalon of segmental trisomy 16 Ts1Cje fetuses, a mouse model for trisomy 21: a novel whole-mount based RNA hybridization study. Brain Res Dev Brain Res 121: 73-78
51. Westendorf JJ, Hiebert SW (1999) Mammalian runt-domain proteins and their roles in hematopoiesis, osteogenesis, and leukaemia. J Cell Biochem [Suppl] 32: 51-58
52. Yang L, Xia L, Wu DY, Wang H, Chansky HA, Schubach WH, Hickstein DD, Zhang Y (2002) Molecular cloning of ESET, a novel histone H3-specific methyltransferase that interacts with ERG transcription factor. Oncogene 21: 148-152
53. Yeghiazaryan K, Turhani-Schatzmann D, Labudova O, Schuller E, Olson EN, Cairns N, Lubec G (1999) Downregulation of the transcription factor scleraxis in brain of patients with Down syndrome. J Neural Transm [Suppl] 57: 305-314
54. Yi H, Fujimura Y, Ouchida M, Prasad DD, Rao VN, Reddy ES (1997) Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias. Oncogene 14: 1259-1268